Petrov Asen, Kappert Utz, Schmidt Torsten, Matschke Klaus Ehrhard, Wilbring Manuel
Department of Cardiac Surgery, University Heart Center Dresden, Dresden, Germany.
Department of Cardiac Anesthesiology, University Heart Center Dresden, Dresden, Germany.
Thorac Cardiovasc Surg. 2023 Jan;71(1):53-61. doi: 10.1055/s-0041-1735960. Epub 2021 Dec 11.
Pyoderma gangrenosum after cardiac surgery is a rare, noninfectious ulcerating skin disease mimicking sternal wound infection.
A systematic search of literature for pyoderma gangrenosum complicating cases of cardiac surgery was conducted between September 1985 and September 2020 on PubMed and Cochrane databases. A systematic review and detailed overview of clinical presentation, diagnostic, treatment, and outcome is provided.
A total of 15 studies enclosing 15 patients suffering from pyoderma gangrenosum following cardiac surgery were identified. Onset of symptoms was observed after a median of 5 days. Patients were predominantly male (81.3%) with a median age of 64 years. Typical clinical presentation mimicked sternal site infection, mainly by means of mediastinitis. Specific signs were rapid progression, erythematous to violaceous color of the wound border, accompanied by unspecific symptoms including fever, malaise, and severe pain. Additionally, pathergy (development of ulcers at the sites of minor cutaneous trauma) was reported frequently. Biopsy is mandatory with a cutaneous neutrophilic inflammation confirming the diagnosis. Initial treatment mostly (75.0% of reported cases) was misled, addressing suspicion of surgical site infection. After correct diagnosis, the treatment was switched to an immunosuppressive therapy. Full sternal wound closure took between 5 weeks and 5 months. Reported case mortality was 12.5% in actually low-risk surgeries.
Despite pyoderma gangrenosum has typical signs, it remains an exclusion diagnosis. The treatment is completely opposite to the main differential diagnosis-the typical surgical site infection. Knowledge about diagnosis and treatment is essential in the context of avoiding fatal mistreatment.
心脏手术后发生的坏疽性脓皮病是一种罕见的、非感染性的溃疡性皮肤病,易被误诊为胸骨伤口感染。
于1985年9月至2020年9月期间在PubMed和Cochrane数据库中对心脏手术并发坏疽性脓皮病的病例进行文献系统检索。对临床表现、诊断、治疗及预后进行系统综述和详细概述。
共纳入15项研究,涉及15例心脏手术后发生坏疽性脓皮病的患者。症状出现的中位时间为术后5天。患者以男性为主(81.3%),中位年龄为64岁。典型的临床表现类似胸骨部位感染,主要表现为纵隔炎。具体体征为进展迅速,伤口边缘由红斑变为紫红色,同时伴有发热、不适和剧痛等非特异性症状。此外,常出现同形反应(轻微皮肤创伤部位出现溃疡)。必须进行活检,皮肤中性粒细胞炎症可确诊。最初的治疗大多(75.0%的报告病例)被误导,针对手术部位感染的怀疑进行处理。正确诊断后,治疗改为免疫抑制治疗。胸骨完全愈合需要5周 至5个月。在实际低风险手术中,报告的病例死亡率为12.5%。
尽管坏疽性脓皮病有典型体征,但仍需排除诊断。其治疗与主要鉴别诊断——典型的手术部位感染完全相反。了解诊断和治疗方法对于避免致命性误治至关重要。